Rhenman & Partners Asset Management Ab Portfolio Holdings
Rhenman & Partners Asset Management Ab
- $959 Million
- Q4 2024
Rhenman & Partners Asset Management Ab has filed its 13F form on February 13, 2025 for Q4 2024 where it was disclosed a total value porftolio of $959 Million distributed in 92 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Boston Scientific Corp with a value of $39.7M, Eli Lilly & CO with a value of $35.1M, Procept Bio Robotics Corp with a value of $33.8M, Intuitive Surgical Inc with a value of $33.4M, and Regeneron Pharmaceuticals, Inc. with a value of $31M.
Examining the 13F form we can see an decrease of $242M in the current position value, from $1.2B to 959M.
Rhenman & Partners Asset Management Ab is based out at Stockholm, V7
Below you can find more details about Rhenman & Partners Asset Management Ab portfolio as well as his latest detailed transactions.